This page shows the latest Rigel news and features for those working in and with pharma, biotech and healthcare.
Rigel already has ongoing pre-clinical activities with its lead CNS penetrant RIPK1 inhibitor candidates. ... We look forward to working with Rigel to advance its clinical development,” he added.
The FDA gave the go-ahead to a pair of rare disease therapies this week, both marking the first-ever approvals for developers Rigel Pharmaceuticals and Ultragenyx. ... Rigel is also developing it for additional indications, including autoimmune
Shares in Rigel Pharmaceuticals fell yesterday after it revealed its lead drug candidate fostamatinib had failed a phase III trial in chronic/persistent immune thrombocytopenia (ITP), a disease leading to reduced ... In August, Rigel reported the same 18
And signs new cancer research partnership with Rigel. Bristol-Myers Squibb will spend big to buy out Flexus Biosciences, a privately-held biotech focused on developing new anti-cancer therapeutics. ... Meanwhile, this announcement was made on the same
The majority of the positions to be eliminated will be in drug discovery, with Rigel looking to focus its pipeline on three lead programmes in relatively late-stage development. ... Rigel said it expects to advance one of these two molecules into a phase
Share plummet after phase II failure of R343. Shares in US pharma company Rigel took a nosedive yesterday after an asthma drug in development at the company failed a phase II ... This was not the result we expected based on the collection of data we had
More from news
Approximately 5 fully matching, plus 12 partially matching documents found.
February saw BMS further signal its intention to lead in this space announcing two simultaneous deals, the acquisition of Flexus Biosciences and a collaboration with Rigel. ... The earlier stage collaborative deal with Rigel is to develop and
Collaboration - develop and commercialise. 342. Rigel Pharmaceuticals/ BMS. Small molecule TGF beta receptor kinase inhibitors - immuno-oncology.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....